Nektar Therapeutics (NASDAQ:NKTR) Shares Purchased by ProShare Advisors LLC
ProShare Advisors LLC increased its stake in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 49.0% in the 4th quarter, Holdings Channel reports. The firm owned 50,277 shares of the biopharmaceutical company’s stock after purchasing an additional 16,543 shares during the period. ProShare Advisors LLC’s holdings in Nektar Therapeutics were worth $47,000 at the […]
